TD Asset Management
MDCO

TD Asset Management’s Medicines Co MDCO Stock Holding History

TD Asset Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-18,300
Closed -$895K – 1401
2017
Q1 		$895K Sell
18,300
-500
-3% -$22.8K ﹤0.01% 1067
2016
Q4 		$638K Buy
18,800
+1,400
+8% +$49.7K ﹤0.01% 1127
2016
Q3 		$657K Buy
17,400
+3,800
+28% +$143K ﹤0.01% 1102
2016
Q2 		$457K Sell
13,600
-1,500
-10% -$52.9K ﹤0.01% 1141
2016
Q1 		$480K Sell
15,100
-500
-3% -$16.3K ﹤0.01% 1107
2015
Q4 		$583K Buy
15,600
+1,700
+12% +$64.2K ﹤0.01% 1070
2015
Q3 		$528K Sell
13,900
-73,100
-84% -$2.57M ﹤0.01% 1057
2015
Q2 		$2.49M Sell
87,000
-1,900
-2% -$52.9K ﹤0.01% 817
2015
Q1 		$2.49M Buy
88,900
+7,700
+9% +$216K ﹤0.01% 799
2014
Q4 		$2.25M Buy
81,200
+4,100
+5% +$102K ﹤0.01% 824
2014
Q3 		$1.72M Sell
77,100
-700
-0.9% -$17.8K ﹤0.01% 842
2014
Q2 		$2.26M Sell
77,800
-77,000
-50% -$2.06M ﹤0.01% 815
2014
Q1 		$4.4M Buy
154,800
+12,100
+8% +$400K 0.01% 672
2013
Q4 		$5.51M Buy
142,700
+5,400
+4% +$193K 0.01% 598
2013
Q3 		$4.6M Buy
137,300
+15,400
+13% +$491K 0.01% 629
2013
Q2 		$3.75M Buy
+121,900
New +$4.08M 0.01% 645

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TD Asset Management's MDCO Position: Q2 2017 in Review

TD Asset Management sold out of Medicines Co (MDCO) in Q2 2017, closing a stake of 18,300 shares — an estimated $895K sold.

TD Asset Management first reported a position in MDCO in Q2 2013 and held it in 16 quarters. The position peaked at $5.51M in Q4 2013. 202 funds tracked by Wall St. Rank hold MDCO as of Q2 2017.

  • TD Asset Management reported no remaining Medicines Co position as of Q2 2017 after selling out during the quarter.
  • TD Asset Management sold 18,300 Medicines Co shares in Q2 2017, an estimated $895K.
  • TD Asset Management first reported a position in Medicines Co in Q2 2013 and held it in 16 quarters.
  • TD Asset Management's Medicines Co position peaked at $5.51M in Q4 2013.
  • 202 funds tracked by Wall St. Rank held Medicines Co as of Q2 2017.

Based on TD Asset Management's 13F filing for Q2 2017, filed 1 Aug 2017.